Skip to content
Back to Blog
Bio
2026-03-178 min read71

Biopharmaceutical cGMP and PIC/S: Global Regulatory Harmonization Trends and SME Strategy

A guide to certification strategies for bio SMEs amid expanding PIC/S membership and cGMP global harmonization.

KITIM 컨설팅팀

The Flow of Global GMP Regulatory Harmonization

As the biopharmaceutical market grows rapidly, GMP regulations across countries are quickly harmonizing around PIC/S (Pharmaceutical Inspection Co-operation Scheme). As of 2026, PIC/S has 56 member countries operating a mutual recognition system for GMP inspection results.

Since joining PIC/S in 2014, Korea has continuously elevated domestic GMP standards to international levels, and applying cGMP (current GMP) standards has become virtually mandatory for biopharmaceuticals.

Differences Between cGMP and Traditional KGMP

Traditional KGMP (Korean GMP)

  • Static standards focused on facilities and equipment
  • Focus on meeting documentation requirements
  • Regular inspection-based management
  • cGMP (Current GMP)

  • Science-based approach
  • Requires Continued Process Verification
  • Mandatory Quality Risk Management (QRM) system
  • Enhanced Data Integrity
  • Real-time monitoring and trend analysis
  • SME Bio Company Response Strategy

    1. Establish QRM System

    The core of cGMP is risk-based approach. Systematic risk management using tools like FMEA and FTA according to ICH Q9 guidelines is required.

    2. Ensure Data Integrity

    The most cited finding in 2026 GMP inspections is data integrity. Apply ALCOA+ principles to all records.

    3. Continuous Process Verification Program

    Beyond traditional 3-batch validation, establish continuous process verification across all production stages. Statistical Process Control (SPC) is key.

    4. PIC/S Inspection GAP Analysis

    Conduct GAP analysis of current manufacturing facilities and quality systems against PIC/S GMP standards to proactively identify areas needing improvement.

    Government Support

  • Biopharmaceutical GMP facility construction support: Subsidies for cleanrooms and aseptic facilities
  • GMP consulting vouchers: Professional consulting cost support for bio SMEs
  • Overseas certification support: Partial funding for FDA, EMA GMP inspection costs
  • Contact KITIM

    KITIM provides professional support for cGMP certification preparation, PIC/S inspection response, and quality system development. Contact us through [KITIM Contact](/contact).

    cGMPPIC/SBiopharmaceuticalsRegulatory HarmonizationGMP Certification

    Related Posts

    Bio

    Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

    Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

    2026-11-09
    Management Consulting

    Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

    Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

    2026-11-09
    Government Programs

    SMEs Can Now Enter the KRW 1,500 Trillion 'Mega Project' Supply Chain from the Design Stage — MSS Joins as a Lead Ministry, Large/Mid-Tier–SME Councils and Regional Councils Launch (Nov 6 Plan to Expand Planning-Stage Participation), and How SMEs Targeting Semiconductor, AI Data Center and Physical AI Supply Chains Should Prepare Validation, Certification and Mass-Production Qualification

    MSS has joined Korea's KRW 1,500 trillion mega projects as a lead ministry and plans to bring SMEs in from the planning stage. This guide covers how the central and regional councils will work and how to line up support programs against the validation, certification and mass-production barriers.

    2026-11-09
    Updated daily

    Let AI find government support programs in this field

    Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

    Get AI-Matched Programs for Free

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.